Smallwood Wealth Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
CWP
DADC
WG
Smallwood Wealth Investment Management's PFE Position: Q2 2026 in Review
Smallwood Wealth Investment Management reduced its Pfizer (PFE) stake by 8.2% in Q2 2026, selling an estimated $10.6K and leaving 4,500 shares worth $108K. The position accounts for 0.05% of the portfolio, ranked #132.
Smallwood Wealth Investment Management first reported a position in PFE in Q4 2021 and has held it in 17 quarters since. The position peaked at $396K in Q4 2021. 990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Smallwood Wealth Investment Management held 4,500 shares of Pfizer worth $108K as of Q2 2026.
- Smallwood Wealth Investment Management sold 404 Pfizer shares in Q2 2026, an estimated $10.6K.
- Pfizer made up 0.05% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #132 holding.
- Smallwood Wealth Investment Management first reported a position in Pfizer in Q4 2021 and has held it in 17 quarters since.
- Smallwood Wealth Investment Management's Pfizer position peaked at $396K in Q4 2021.
- 990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.